Subconjunctival Mitomycin Injection | One Eye (PF only) - ROQUE Eye Clinic

This is an image of a tuberculin syringe aspirating a compounded solution for subconjunctival Mitomycin injection.

PRICE

₱ 16,800.00

OVERVIEW, TERMS & CONTACT INFO

OVERVIEW

Subconjunctival mitomycin-C injection delivers an anti-scarring medicine under the eye surface to support selected eye surgeries and high-risk healing cases. It helps reduce excessive scar formation and improves procedure durability. Careful dosing, sterile technique, and structured follow-up are essential for safety and effectiveness.

TERMS AND CONDITIONS, INCLUSIONS, AND EXCLUSIONS

1. Service includes subconjunctival mitomycin-C injection for one eye and surgeon professional services only.
2. The published price refers to the surgeon’s professional fee for one eye only. The final net amount may be reduced after applicable discounts, such as Senior Citizen or PWD benefits.
3. If the procedure is performed under general anesthesia, a fifty percent premium is added to the surgeon’s professional fee.
4. Hospital fees, facility charges, and related surgical supplies are billed separately and are paid directly by the patient.
5. Final indication and dosing require full ophthalmic evaluation and diagnostics. Clinical response varies and outcomes are not guaranteed.
6. When applicable, PhilHealth pre-approval is required. Insurance or HMO cases require an approved letter of authority or guarantee letter before the procedure.
7. A daily hospital room rate charge applies to all admissions and is billed separately by the hospital based on room type and length of stay.

CONTACT INFORMATION

Dr. Manolette Roque | Dr. Barbara Roque
St. Luke’s Medical Center – Global City
2nd Floor, Units 217-218, Roque Eye Clinic, Medical Arts Building
Rizal Drive cor. 5th Ave, Taguig City 1634, Philippines
+63-917-844-2020
+63-998-998-2020
+63-2-8828-2020
+63-2-8789-7700 ext. 7217
+63-2-8789-7700 ext. 7218

Dr. Manolette Roque | Dr. Barbara Roque
Asian Hospital and Medical Center
5th Floor, Unit 509, Roque Eye Clinic, Medical Office Building
2205 Civic Drive, Alabang, Muntinlupa City 1781, Philippines
+63-917-795-2020
+63-998-997-2020
+63-2-8771-9253
+63-2-8771-9000 ext. 7509

DETAILS

SUBCONJUNCTIVAL MITOMYCIN-C INJECTION

Subconjunctival mitomycin-C injection is an adjunctive ophthalmic service that delivers a controlled dose of mitomycin-C beneath the conjunctiva to modulate wound healing. Ophthalmologists use this service to reduce scarring and fibroblast activity in selected eye conditions and procedures. As a result, it supports improved surgical outcomes when excessive tissue response may compromise success.

WHAT THIS SERVICE TREATS

This service targets conditions where abnormal scarring or aggressive healing can limit treatment effectiveness. Surgeons commonly use it in glaucoma-related procedures, pterygium management, and other surgeries that benefit from scar control. Therefore, the ophthalmologist confirms the indication through examination and clinical assessment before recommending treatment.

HOW THE PROCEDURE WORKS

First, the ophthalmologist applies topical anesthesia to ensure comfort. Next, the surgeon injects a carefully measured dose of mitomycin-C beneath the conjunctiva at a targeted site. The medication acts locally to suppress fibroblast proliferation. Consequently, it reduces postoperative scarring while preserving surrounding tissue integrity.

WHO MAY BENEFIT

Subconjunctival mitomycin-C injection may benefit selected patients who require controlled healing response. For example, it may support care in the following situations.

1. Patients undergoing glaucoma filtering procedures
2. Eyes at high risk of postoperative scarring
3. Recurrent pterygium or aggressive conjunctival growths
4. Selected revision surgeries where fibrosis may recur
5. Cases requiring adjunctive wound modulation

RECOVERY AND AFTERCARE

Patients usually resume routine activities shortly after the injection. Mild redness or irritation may occur temporarily. However, prescribed eye drops and follow-up visits help ensure safe recovery. Therefore, adherence to postoperative instructions remains important for optimal results.

SAFETY AND CLINICAL CONSIDERATIONS

When used appropriately, mitomycin-C provides effective scar control. However, careful dosing and proper case selection remain essential. The ophthalmologist evaluates eye surface health, healing capacity, and overall risk before treatment. Ongoing monitoring further supports safe outcomes.